PARTICIPANT FEATURES |
1 Gender |
2–6 Ethnicity |
7 Economic study consent |
8 Depressed mood |
9 Diminished interest or pleasure |
10 Weight loss while not dieting |
11 Insomnia or hypersomnia |
12 Psychomotor agitation or retardation |
13 Fatigue or loss of energy |
14 Feelings of worthless or guilt |
15 Diminished ability to concentrate |
16 Recurrent thoughts of death or suicide |
17 Age |
18 Number of relatives living with patient |
19 Number of friends living with patient |
20 Total number of persons in household |
21 Years of schooling completed |
22 Highest degree received |
23 On medical or psychiatric leave |
24 Medicare |
25 Medicaid |
26 Private insurance |
27 Better able make important decisions |
28 Better able to enjoy things |
29 Impact of your family and friends |
30–35 Current marital status |
36–41 Current employment status |
42–44 Currently a student |
45–46 Currently do volunteer work |
|
ILLNESS FEATURES |
47–60 Cumulative Illness Rating Scale |
61–78 Hamilton rating scale for depression |
79–93 Quick Inventory of Depressive Symptomatology |
94–97 Medication history |
98–236 Psychiatric diagnostic screening questionare |
237 Baseline Axis I psychiatric condition |
238 Baseline Axis II psychiatric condition |
239 Family hx depression |
240 Family hx bipolar disorder |
241 Family hx alcohol abuse |
242 Family hx drug abuse |
243 Family hx suicide |
INTERMEDIATE MEDICAL CONDITIONS |
244–294 Patient rated inventory of side effects |
295 AIDS-C percent improvement |
296 QIDS-C score change rate |
297 QIDS-SR score change rate |
298 FISER frequency score change rate |
299 FISER intensity score change rate |
300 GRSEB score change rate |
301 CGII score change rate |
302 Patient presently a suicide risk |
303 Patient in remission |
304 Study medical daily dose |
|
CARE FEATURES |
305 Type of clinical site |
|